Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of VAB versus standard triple therapy for Helicobacter pylori eradication
TCTR20210928005Phase 4Unknown
- Sponsor
- Department of Medicine, Phramongkutklao Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan, amoxicillin, bismuth subsalicylate in Helicobacter pylori infection, sponsored by Department of Medicine, Phramongkutklao Hospital. Status: unknown.
02
Drugs
vonoprazanamoxicillinbismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20210928005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210928005.